COMMUNIQUÉS West-GlobeNewswire

ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026
03/08/2026
Company to host investor conference call and webcast at 4:30 p.m. ET. Cambridge, Massachusetts, Aug. 03, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company [...]
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/08/2026
CAMBRIDGE, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted 2 newly- [...]
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results
03/08/2026
ZUG, Switzerland and BOSTON, Aug. 03, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the second quarter ended June 30, 2026. "The second quarter reflected strong [...]
CapsoVision® Announces International Launch of AI Highlights
03/08/2026
AI-assisted review feature designed to support physician review of small bowel capsule endoscopy studies using the CapsoCam Plus® system SARATOGA, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV [...]
Keros Therapeutics Reports Second Quarter 2026 Financial Results
03/08/2026
LEXINGTON, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel [...]
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/08/2026
SAN DIEGO, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib [...]
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/08/2026
NEEDHAM, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve [...]
argenx announces Extraordinary General Meeting of Shareholders on September 17, 2026
03/08/2026
August 3, 2026 – 22:01 PM CEST Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology innovation company committed to improving the lives of people suffering from severe autoimmune [...]
Longeveron to Report 2026 Second Quarter Financial Results and Host Conference Call on August 12, 2026
03/08/2026
MIAMI, Fla., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related [...]
Fractyl Health to Report Second Quarter 2026 Financial Results and Provide Business Updates on August 10, 2026
03/08/2026
BURLINGTON, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company or Fractyl), a clinical-stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity [...]
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/08/2026
BOSTON, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Damora Therapeutics, Inc. (NASDAQ: DMRA) (“Damora”), a biotechnology company working to fundamentally redefine care for patients with blood disorders, today announced that it [...]
Dianthus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
04/08/2026
NEW YORK and WALTHAM, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the [...]
Seer to Report Second Quarter 2026 Financial Results on August 11, 2026
03/08/2026
REDWOOD CITY, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial results for the [...]
Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
03/08/2026
Announced Vertex Agreement to Acquire Crinetics for Total Equity Value of Approximately $10.0 Billion, or Approximately $8.8B Net of Estimated Cash Acquired PALSONIFY® (Paltusotine) Net Product Revenue of $24.0 Million [...]
Inspire Medical Systems, Inc. Announces Second Quarter 2026 Financial Results, Raised 2026 Guidance, and Strategic Growth Plan
03/08/2026
Generated second quarter revenue of $200.6 million Second quarter diluted EPS of $0.01; adjusted diluted EPS of $0.14 Second quarter operating cash flow of $23.2 million Announced strategic growth plan designed to [...]
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance
03/08/2026
Delivered ~ 15% WW revenue growth and ~ 178% increase in adjusted EBITDA ~ 19% increase in U.S. physician base Second Quarter 2026 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of [...]
REACT19 Launches $100,000 Matching Campaign as Demand for Medical Grants Surges 33%
03/08/2026
Six families need help today. Fifteen more are already waiting. Every donation through September will be doubled to provide life-saving medical care MEQUON, Wisc., Aug. 03, 2026 (GLOBE NEWSWIRE) -- REACT19 today [...]
A Race Against Blindness Launches New Research Grants Program to Accelerate Treatments for Inherited Retinal Diseases and Bardet-Biedl Syndrome
03/08/2026
New grant program announced at the Bardet-Biedl Syndrome Foundation Annual Conference invites researchers worldwide to apply for funding GILBERT, Ariz., Aug. 03, 2026 (GLOBE NEWSWIRE) -- A Race Against Blindness today [...]
The Ferrari Foundation Advances Fifth Annual Adam Ferrari Health Science Scholarship to Finalist Review
03/08/2026
Three finalists will be selected for the $20,000 scholarship before the recipient is announced on September 1 IRVINE, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Ferrari Foundation has begun the finalist selection [...]

Pages